May 25 (Reuters) - Aroa Biosurgery Ltd (ARX) :
- FY22 PRODUCT SALES GUIDANCE OF $30M-33M
- TOTAL REVENUE FOR FY21 WAS $22.3M
- NORMALISED LOSS BEFORE INCOME TAX FOR FY21 WAS $7.4M
- PRODUCT GROSS MARGINS EXPECTED TO IMPROVE IN H2 FY22
News: ARX Aroa Biosurgery Posts FY22 Product Sales Guidance Of $30M-33M
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
0.015(2.46%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| 61.0¢ | 63.0¢ | 61.0¢ | $218.7K | 351.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 34667 | 62.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 63.0¢ | 59182 | 6 |
View Market Depth
| Last trade - 12.25pm 12/08/2025 (20 minute delay) ? |
| ARX (ASX) Chart |